I note also that there have been plenty of Aussie companies that focused on excellent R&D at the expense of commercialisation that are no longer with us.
PolyNovo has escaped that fate and in the years to come will have, no doubt, a broad portfolio of NovoSorb products just because in its early days it focused on bringing in the dollars.
Medtronic has entered the market for resorbable mesh Ventral Hernia Repair, page-16
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.53 |
Change
-0.010(0.39%) |
Mkt cap ! $1.746B | |||
| Open | High | Low | Value | Volume |
| $2.55 | $2.56 | $2.50 | $1.681M | 664.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 18351 | $2.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.53 | 36182 | 25 |
View Market Depth
| Last trade - 14.55pm 13/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |